-transparent.png){kind=logo}
While there is considerable evidence demonstrating altered activity of the major isoforms of protein kinase C (PKC) in the vasculature and neurons of Alzheimer disease (AD) brains, little is known about the activity and/or levels of the atypical PKC isoforms. The objective of this study is to compare PKC-zeta activity and level in cerebral microvessels isolated from AD brains with microvessels from the brains of nondemented age-matched controls. Measurements of the kinase activity reveals that the PKC-zeta activity is significantly (P < 0.01) lower in AD brain microvessels compared with vessels from control brain. Despite this decrease in enzyme activity, the level of PKC-zeta, assessed by Western blot, is significantly (P < 0.01) elevated in AD microvessels. These data demonstrate significant and divergent changes in the PKC-zeta activity and level in the microcirculation of the AD brain and suggest that aberrant regulation of microvascular PKC-zeta could contribute to the abnormal signaling mechanisms at the blood-brain barrier in the AD brain.
P Moore, and
J White, and
V Christiansen, and
P Grammas
January 1995,
Neurobiology of aging,
P Moore, and
J White, and
V Christiansen, and
P Grammas
October 1992,
Annals of neurology,
P Moore, and
J White, and
V Christiansen, and
P Grammas
December 1995,
Molecular and chemical neuropathology,
P Moore, and
J White, and
V Christiansen, and
P Grammas
August 1997,
Brain research,
P Moore, and
J White, and
V Christiansen, and
P Grammas
December 1999,
The Journal of biological chemistry,
P Moore, and
J White, and
V Christiansen, and
P Grammas
July 1992,
FEBS letters,
P Moore, and
J White, and
V Christiansen, and
P Grammas
December 1998,
The Journal of pharmacology and experimental therapeutics,
P Moore, and
J White, and
V Christiansen, and
P Grammas
January 2013,
PloS one,
P Moore, and
J White, and
V Christiansen, and
P Grammas
November 1991,
Neuroscience letters,
P Moore, and
J White, and
V Christiansen, and
P Grammas
May 2007,
Proteins,
